Skip to main content
MorphoSys AG logo

MorphoSys AG — Investor Relations & Filings

Ticker · MOR ISIN · DE000A3H2XW6 LEI · 529900493806K77LRE72 F Manufacturing
Open in API
Filings indexed 1,418 across all filing types
Latest filing 2023-03-27 Declaration of Voting R…
Country DE Germany
Listing F MOR

About MorphoSys AG

https://www.morphosys.com/

MorphoSys AG is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicines, primarily for cancer patients. The company specializes in creating therapeutic monoclonal antibodies, utilizing its long-standing expertise and proprietary technology platforms to generate fully human antibodies. Its research and development efforts are concentrated on building a pipeline of novel treatments to address significant unmet medical needs in oncology. In February 2024, Novartis entered into an agreement to acquire MorphoSys, aiming to integrate its antibody technologies and oncology pipeline.

Recent filings

Filing Released Lang Actions
Declaration of Voting Results & Voting Rights Announcements 2023
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is explicitly titled 'Voting Rights Announcements' and contains detailed tables reporting changes in share ownership, voting rights percentages, and instruments held by a major shareholder (The Goldman Sachs Group, Inc.) in MorphoSys AG, referencing specific German securities laws (WpHG, Sec. 40, 33, 34, 38). This content directly corresponds to the definition of a notification regarding changes in significant share ownership thresholds, which aligns best with the 'Major Shareholding Notification' category (MRQ). Although it mentions 'Voting Rights Announcements' in the header, the core content is the detailed breakdown of holdings crossing thresholds, which is the essence of an MRQ filing.
2023-03-27 English
MorphoSys AG: Repurchase of portion of outstanding convertible bonds due 2025 (ISIN DE000A3H2XW6)
Capital/Financing Update Classification · 1% confidence The document is a news release dated March 24, 2023, announcing the 'Repurchase of portion of outstanding convertible bonds due 2025'. This action involves the company buying back its own debt instruments (bonds). This activity directly relates to changes in the company's capital structure or treasury stock management, specifically the repurchase of debt securities. Reviewing the definitions, 'Transaction in Own Shares (Code: POS)' covers the company buying back or selling its own shares. While this is debt repurchase, it is a direct capital management/treasury activity. However, 'Capital/Financing Update (Code: CAP)' covers 'Updates on company fundraising, financing activities, or capital structure changes.' The repurchase of convertible bonds is a significant financing activity that alters the capital structure. Given the options, 'CAP' is the most appropriate fit for a significant debt repurchase/restructuring announcement, as 'POS' is explicitly defined for shares. Since this is a formal announcement of a completed transaction affecting financing, it is not a general 'RNS' or 'RPA'.
2023-03-24 English
Declaration of Voting Results & Voting Rights Announcements 2023
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is explicitly titled 'Voting Rights Announcements' and contains detailed tables reporting changes in share ownership, voting rights attached to shares, and rights through financial instruments (like options and swaps) held by a major shareholder (The Goldman Sachs Group, Inc.) in MorphoSys AG. This directly corresponds to the definition of a notification regarding changes in significant share ownership levels, which aligns with the 'Major Shareholding Notification' category (MRQ). Although the header mentions 'Voting Rights Announcements', the content structure (reporting thresholds crossed, total positions, details of instruments) is characteristic of a major holding disclosure, which is often cross-referenced with voting rights announcements in European regulations (like the WpHG mentioned). MRQ is the most specific fit for this type of disclosure.
2023-03-23 English
Declaration of Voting Results & Voting Rights Announcements 2023
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is explicitly titled 'Voting Rights Announcements' and contains detailed tables reporting changes in share ownership, voting rights percentages, and details of instruments held by a major shareholder (The Goldman Sachs Group, Inc.) in MorphoSys AG. This directly corresponds to the definition of a Major Shareholding Notification, which tracks changes in significant ownership levels crossing thresholds. The German WpHG reference further confirms this is a regulatory disclosure related to shareholdings. Therefore, the appropriate code is MRQ.
2023-03-23 English
MorphoSys AG invites all eligible holders to offer to sell for cash their convertible bonds due 2025 (ISIN DE000A3H2XW6)
Capital/Financing Update Classification · 1% confidence The document is a press release dated March 23, 2023, announcing that MorphoSys AG is inviting eligible holders to offer to sell their convertible bonds due 2025 for cash via a modified reverse Dutch auction. This action relates to the company intending to repurchase and cancel a portion of its outstanding debt/bonds. This activity falls under financing or capital structure changes. Reviewing the definitions, 'Capital/Financing Update (Code: CAP)' is the most appropriate category as it covers 'Updates on company fundraising, financing activities, or capital structure changes.' The document details the terms of a bond repurchase offer, which is a financing activity.
2023-03-23 English
Declaration of Voting Results & Voting Rights Announcements 2023
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled 'Voting Rights Announcements' and explicitly states 'Notification of Major Holdings' under German Securities Trading Act (WpHG). It details changes in voting rights percentages held by a major shareholder (The Goldman Sachs Group, Inc.) in MorphoSys AG, crossing specific thresholds. This content directly corresponds to regulatory filings concerning changes in significant share ownership, which matches the definition for Major Shareholding Notification (MRQ). Although it is a regulatory announcement disseminated via EQS News, the core content is the notification itself, not just an announcement of a report's publication (RPA/RNS).
2023-03-21 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.